Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Index by author

June 01, 1988; Volume 33,Issue 6
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

A

  1. Ahir, S

    1. You have access
      Substrate properties of analogs of myo-inositol.
      J D Moyer, O Reizes, S Ahir, C Jiang, N Malinowski and D C Baker
      Molecular Pharmacology June 1988, 33 (6) 683-689;
  2. Akita, Y

    1. You have access
      Effects of cholera toxin on the coupling of thyrotropin-releasing hormone to a guanine nucleotide-binding protein in cultured GH3 cells.
      Y Yajima, Y Akita and T Saito
      Molecular Pharmacology June 1988, 33 (6) 592-597;
  3. Altar, C A

    1. You have access
      Dopamine release and metabolism after chronic delivery of selective or nonselective dopamine autoreceptor agonists.
      C A Altar, B Berner, P Beall, S F Carlsen and W C Boyar
      Molecular Pharmacology June 1988, 33 (6) 690-695;

B

  1. Baker, D C

    1. You have access
      Substrate properties of analogs of myo-inositol.
      J D Moyer, O Reizes, S Ahir, C Jiang, N Malinowski and D C Baker
      Molecular Pharmacology June 1988, 33 (6) 683-689;
  2. Beall, P

    1. You have access
      Dopamine release and metabolism after chronic delivery of selective or nonselective dopamine autoreceptor agonists.
      C A Altar, B Berner, P Beall, S F Carlsen and W C Boyar
      Molecular Pharmacology June 1988, 33 (6) 690-695;
  3. Berner, B

    1. You have access
      Dopamine release and metabolism after chronic delivery of selective or nonselective dopamine autoreceptor agonists.
      C A Altar, B Berner, P Beall, S F Carlsen and W C Boyar
      Molecular Pharmacology June 1988, 33 (6) 690-695;
  4. Blanton, M

    1. You have access
      Noncompetitive inhibitors reach their binding site in the acetylcholine receptor by two different paths.
      M Blanton, E McCardy, T Gallaher and H H Wang
      Molecular Pharmacology June 1988, 33 (6) 634-642;
  5. Borchardt, R T

    1. You have access
      Effects of 9-(trans-2',trans-3'-dihydroxycyclopent-4'-enyl)-adenine and -3-deazaadenine on the metabolism of S-adenosylhomocysteine in mouse L929 cells.
      M Hasobe, J G Mckee, D R Borcherding, B T Keller and R T Borchardt
      Molecular Pharmacology June 1988, 33 (6) 713-720;
  6. Borcherding, D R

    1. You have access
      Effects of 9-(trans-2',trans-3'-dihydroxycyclopent-4'-enyl)-adenine and -3-deazaadenine on the metabolism of S-adenosylhomocysteine in mouse L929 cells.
      M Hasobe, J G Mckee, D R Borcherding, B T Keller and R T Borchardt
      Molecular Pharmacology June 1988, 33 (6) 713-720;
  7. Boyar, W C

    1. You have access
      Dopamine release and metabolism after chronic delivery of selective or nonselective dopamine autoreceptor agonists.
      C A Altar, B Berner, P Beall, S F Carlsen and W C Boyar
      Molecular Pharmacology June 1988, 33 (6) 690-695;
  8. Brown, A M

    1. You have access
      Kinetic studies on the mechanism by which histamine H1 receptors potentiate cyclic AMP accumulation in guinea pig cerebral cortical slices.
      J Donaldson, S J Hill and A M Brown
      Molecular Pharmacology June 1988, 33 (6) 626-633;

C

  1. Carlsen, S F

    1. You have access
      Dopamine release and metabolism after chronic delivery of selective or nonselective dopamine autoreceptor agonists.
      C A Altar, B Berner, P Beall, S F Carlsen and W C Boyar
      Molecular Pharmacology June 1988, 33 (6) 690-695;
  2. Casida, J E

    1. You have access
      Partial characterization of specific cantharidin binding sites in mouse tissues.
      M J Graziano, I N Pessah, M Matsuzawa and J E Casida
      Molecular Pharmacology June 1988, 33 (6) 706-712;
  3. Chijiwa, T

    1. You have access
      ML-9 inhibits the vascular contraction via the inhibition of myosin light chain phosphorylation.
      T Ishikawa, T Chijiwa, M Hagiwara, S Mamiya, M Saitoh and H Hidaka
      Molecular Pharmacology June 1988, 33 (6) 598-603;
  4. Christova, T Y

    1. You have access
      Functional in vitro test of calmodulin antagonism: effect of drugs on interaction between calmodulin and glycolytic enzymes.
      F Orosz, T Y Christova and J Ovádi
      Molecular Pharmacology June 1988, 33 (6) 678-682;
  5. Cragoe, E J

    1. You have access
      Demonstration of a [K+,Cl-]-cotransport system in human red cells by its sensitivity to [(dihydroindenyl)oxy]alkanoic acids: regulation of cell swelling and distinction from the bumetanide-sensitive [Na+,K+,Cl-]-cotransport system.
      R P Garay, C Nazaret, P A Hannaert and E J Cragoe
      Molecular Pharmacology June 1988, 33 (6) 696-701;
  6. Craig, R H

    1. You have access
      125I-BW-A844U, an antagonist radioligand with high affinity and selectivity for adenosine A1 receptors, and 125I-azido-BW-A844U, a photoaffinity label.
      A Patel, R H Craig, S M Daluge and J Linden
      Molecular Pharmacology June 1988, 33 (6) 585-591;
  7. Crooks, P A

    1. You have access
      Stereoselectivity in the N'-oxidation of nicotine isomers by flavin-containing monooxygenase.
      L A Damani, W F Pool, P A Crooks, R K Kaderlik and D M Ziegler
      Molecular Pharmacology June 1988, 33 (6) 702-705;

D

  1. Daluge, S M

    1. You have access
      125I-BW-A844U, an antagonist radioligand with high affinity and selectivity for adenosine A1 receptors, and 125I-azido-BW-A844U, a photoaffinity label.
      A Patel, R H Craig, S M Daluge and J Linden
      Molecular Pharmacology June 1988, 33 (6) 585-591;
  2. Damani, L A

    1. You have access
      Stereoselectivity in the N'-oxidation of nicotine isomers by flavin-containing monooxygenase.
      L A Damani, W F Pool, P A Crooks, R K Kaderlik and D M Ziegler
      Molecular Pharmacology June 1988, 33 (6) 702-705;
  3. Danilowicz, R M

    1. You have access
      Role of arachidonic acid metabolism in the mitogenic response of BALB/c 3T3 fibroblasts to epidermal growth factor.
      R D Nolan, R M Danilowicz and T E Eling
      Molecular Pharmacology June 1988, 33 (6) 650-656;
  4. Darchen, F

    1. You have access
      Ketanserin binds to the monoamine transporter of chromaffin granules and of synaptic vesicles.
      F Darchen, D Scherman, P M Laduron and J P Henry
      Molecular Pharmacology June 1988, 33 (6) 672-677;
  5. Donaldson, J

    1. You have access
      Kinetic studies on the mechanism by which histamine H1 receptors potentiate cyclic AMP accumulation in guinea pig cerebral cortical slices.
      J Donaldson, S J Hill and A M Brown
      Molecular Pharmacology June 1988, 33 (6) 626-633;

E

  1. Eling, T E

    1. You have access
      Role of arachidonic acid metabolism in the mitogenic response of BALB/c 3T3 fibroblasts to epidermal growth factor.
      R D Nolan, R M Danilowicz and T E Eling
      Molecular Pharmacology June 1988, 33 (6) 650-656;

G

  1. Gallaher, T

    1. You have access
      Noncompetitive inhibitors reach their binding site in the acetylcholine receptor by two different paths.
      M Blanton, E McCardy, T Gallaher and H H Wang
      Molecular Pharmacology June 1988, 33 (6) 634-642;
  2. Garay, R P

    1. You have access
      Demonstration of a [K+,Cl-]-cotransport system in human red cells by its sensitivity to [(dihydroindenyl)oxy]alkanoic acids: regulation of cell swelling and distinction from the bumetanide-sensitive [Na+,K+,Cl-]-cotransport system.
      R P Garay, C Nazaret, P A Hannaert and E J Cragoe
      Molecular Pharmacology June 1988, 33 (6) 696-701;
  3. Giraldo, E

    1. You have access
      Characterization of muscarinic receptors in guinea pig ileum longitudinal smooth muscle.
      E Giraldo, M A Viganò, R Hammer and H Ladinsky
      Molecular Pharmacology June 1988, 33 (6) 617-625;
  4. Graziano, M J

    1. You have access
      Partial characterization of specific cantharidin binding sites in mouse tissues.
      M J Graziano, I N Pessah, M Matsuzawa and J E Casida
      Molecular Pharmacology June 1988, 33 (6) 706-712;

H

  1. Hagiwara, M

    1. You have access
      ML-9 inhibits the vascular contraction via the inhibition of myosin light chain phosphorylation.
      T Ishikawa, T Chijiwa, M Hagiwara, S Mamiya, M Saitoh and H Hidaka
      Molecular Pharmacology June 1988, 33 (6) 598-603;
  2. Hammer, R

    1. You have access
      Characterization of muscarinic receptors in guinea pig ileum longitudinal smooth muscle.
      E Giraldo, M A Viganò, R Hammer and H Ladinsky
      Molecular Pharmacology June 1988, 33 (6) 617-625;
  3. Hannaert, P A

    1. You have access
      Demonstration of a [K+,Cl-]-cotransport system in human red cells by its sensitivity to [(dihydroindenyl)oxy]alkanoic acids: regulation of cell swelling and distinction from the bumetanide-sensitive [Na+,K+,Cl-]-cotransport system.
      R P Garay, C Nazaret, P A Hannaert and E J Cragoe
      Molecular Pharmacology June 1988, 33 (6) 696-701;
  4. Hartzell, H C

    1. You have access
      Role of phosphodiesterase in regulation of calcium current in isolated cardiac myocytes.
      M A Simmons and H C Hartzell
      Molecular Pharmacology June 1988, 33 (6) 664-671;
  5. Hasobe, M

    1. You have access
      Effects of 9-(trans-2',trans-3'-dihydroxycyclopent-4'-enyl)-adenine and -3-deazaadenine on the metabolism of S-adenosylhomocysteine in mouse L929 cells.
      M Hasobe, J G Mckee, D R Borcherding, B T Keller and R T Borchardt
      Molecular Pharmacology June 1988, 33 (6) 713-720;
  6. Henry, J P

    1. You have access
      Ketanserin binds to the monoamine transporter of chromaffin granules and of synaptic vesicles.
      F Darchen, D Scherman, P M Laduron and J P Henry
      Molecular Pharmacology June 1988, 33 (6) 672-677;
  7. Hidaka, H

    1. You have access
      ML-9 inhibits the vascular contraction via the inhibition of myosin light chain phosphorylation.
      T Ishikawa, T Chijiwa, M Hagiwara, S Mamiya, M Saitoh and H Hidaka
      Molecular Pharmacology June 1988, 33 (6) 598-603;
  8. Hill, S J

    1. You have access
      Kinetic studies on the mechanism by which histamine H1 receptors potentiate cyclic AMP accumulation in guinea pig cerebral cortical slices.
      J Donaldson, S J Hill and A M Brown
      Molecular Pharmacology June 1988, 33 (6) 626-633;
  9. Hixon, J

    1. You have access
      Long-lasting agonist activity produced by a capsaicin-like photoaffinity probe.
      I F James, C S Walpole, J Hixon, J N Wood and R Wrigglesworth
      Molecular Pharmacology June 1988, 33 (6) 643-649;
  10. Humphreys, C J

    1. You have access
      Antidepressant binding to the porcine and human platelet serotonin transporters.
      C J Humphreys, J Levin and G Rudnick
      Molecular Pharmacology June 1988, 33 (6) 657-663;

I

  1. Ishikawa, T

    1. You have access
      ML-9 inhibits the vascular contraction via the inhibition of myosin light chain phosphorylation.
      T Ishikawa, T Chijiwa, M Hagiwara, S Mamiya, M Saitoh and H Hidaka
      Molecular Pharmacology June 1988, 33 (6) 598-603;

J

  1. James, I F

    1. You have access
      Long-lasting agonist activity produced by a capsaicin-like photoaffinity probe.
      I F James, C S Walpole, J Hixon, J N Wood and R Wrigglesworth
      Molecular Pharmacology June 1988, 33 (6) 643-649;
  2. Jiang, C

    1. You have access
      Substrate properties of analogs of myo-inositol.
      J D Moyer, O Reizes, S Ahir, C Jiang, N Malinowski and D C Baker
      Molecular Pharmacology June 1988, 33 (6) 683-689;

K

  1. Kaderlik, R K

    1. You have access
      Stereoselectivity in the N'-oxidation of nicotine isomers by flavin-containing monooxygenase.
      L A Damani, W F Pool, P A Crooks, R K Kaderlik and D M Ziegler
      Molecular Pharmacology June 1988, 33 (6) 702-705;
  2. Keller, B T

    1. You have access
      Effects of 9-(trans-2',trans-3'-dihydroxycyclopent-4'-enyl)-adenine and -3-deazaadenine on the metabolism of S-adenosylhomocysteine in mouse L929 cells.
      M Hasobe, J G Mckee, D R Borcherding, B T Keller and R T Borchardt
      Molecular Pharmacology June 1988, 33 (6) 713-720;

L

  1. Ladinsky, H

    1. You have access
      Characterization of muscarinic receptors in guinea pig ileum longitudinal smooth muscle.
      E Giraldo, M A Viganò, R Hammer and H Ladinsky
      Molecular Pharmacology June 1988, 33 (6) 617-625;
  2. Laduron, P M

    1. You have access
      Ketanserin binds to the monoamine transporter of chromaffin granules and of synaptic vesicles.
      F Darchen, D Scherman, P M Laduron and J P Henry
      Molecular Pharmacology June 1988, 33 (6) 672-677;
  3. Levin, J

    1. You have access
      Antidepressant binding to the porcine and human platelet serotonin transporters.
      C J Humphreys, J Levin and G Rudnick
      Molecular Pharmacology June 1988, 33 (6) 657-663;
  4. Linden, J

    1. You have access
      125I-BW-A844U, an antagonist radioligand with high affinity and selectivity for adenosine A1 receptors, and 125I-azido-BW-A844U, a photoaffinity label.
      A Patel, R H Craig, S M Daluge and J Linden
      Molecular Pharmacology June 1988, 33 (6) 585-591;

M

  1. Malinowski, N

    1. You have access
      Substrate properties of analogs of myo-inositol.
      J D Moyer, O Reizes, S Ahir, C Jiang, N Malinowski and D C Baker
      Molecular Pharmacology June 1988, 33 (6) 683-689;
  2. Mamiya, S

    1. You have access
      ML-9 inhibits the vascular contraction via the inhibition of myosin light chain phosphorylation.
      T Ishikawa, T Chijiwa, M Hagiwara, S Mamiya, M Saitoh and H Hidaka
      Molecular Pharmacology June 1988, 33 (6) 598-603;
  3. Matsuzawa, M

    1. You have access
      Partial characterization of specific cantharidin binding sites in mouse tissues.
      M J Graziano, I N Pessah, M Matsuzawa and J E Casida
      Molecular Pharmacology June 1988, 33 (6) 706-712;
  4. McCardy, E

    1. You have access
      Noncompetitive inhibitors reach their binding site in the acetylcholine receptor by two different paths.
      M Blanton, E McCardy, T Gallaher and H H Wang
      Molecular Pharmacology June 1988, 33 (6) 634-642;
  5. Mckee, J G

    1. You have access
      Effects of 9-(trans-2',trans-3'-dihydroxycyclopent-4'-enyl)-adenine and -3-deazaadenine on the metabolism of S-adenosylhomocysteine in mouse L929 cells.
      M Hasobe, J G Mckee, D R Borcherding, B T Keller and R T Borchardt
      Molecular Pharmacology June 1988, 33 (6) 713-720;
  6. Miller, R J

    1. You have access
      Multiple sites for the regulation of the N-methyl-D-aspartate receptor.
      I J Reynolds and R J Miller
      Molecular Pharmacology June 1988, 33 (6) 581-584;
  7. Moyer, J D

    1. You have access
      Substrate properties of analogs of myo-inositol.
      J D Moyer, O Reizes, S Ahir, C Jiang, N Malinowski and D C Baker
      Molecular Pharmacology June 1988, 33 (6) 683-689;

N

  1. Nakamura, S

    1. You have access
      Low concentration of reserpine accelerates actin polymerization via interaction with G-actin.
      S Nakamura, K Ohmi and Y Nonomura
      Molecular Pharmacology June 1988, 33 (6) 604-610;
  2. Nazaret, C

    1. You have access
      Demonstration of a [K+,Cl-]-cotransport system in human red cells by its sensitivity to [(dihydroindenyl)oxy]alkanoic acids: regulation of cell swelling and distinction from the bumetanide-sensitive [Na+,K+,Cl-]-cotransport system.
      R P Garay, C Nazaret, P A Hannaert and E J Cragoe
      Molecular Pharmacology June 1988, 33 (6) 696-701;
  3. Nolan, R D

    1. You have access
      Role of arachidonic acid metabolism in the mitogenic response of BALB/c 3T3 fibroblasts to epidermal growth factor.
      R D Nolan, R M Danilowicz and T E Eling
      Molecular Pharmacology June 1988, 33 (6) 650-656;
  4. Nonomura, Y

    1. You have access
      Low concentration of reserpine accelerates actin polymerization via interaction with G-actin.
      S Nakamura, K Ohmi and Y Nonomura
      Molecular Pharmacology June 1988, 33 (6) 604-610;

O

  1. Ohmi, K

    1. You have access
      Low concentration of reserpine accelerates actin polymerization via interaction with G-actin.
      S Nakamura, K Ohmi and Y Nonomura
      Molecular Pharmacology June 1988, 33 (6) 604-610;
  2. Orosz, F

    1. You have access
      Functional in vitro test of calmodulin antagonism: effect of drugs on interaction between calmodulin and glycolytic enzymes.
      F Orosz, T Y Christova and J Ovádi
      Molecular Pharmacology June 1988, 33 (6) 678-682;
  3. Ovádi, J

    1. You have access
      Functional in vitro test of calmodulin antagonism: effect of drugs on interaction between calmodulin and glycolytic enzymes.
      F Orosz, T Y Christova and J Ovádi
      Molecular Pharmacology June 1988, 33 (6) 678-682;

P

  1. Patel, A

    1. You have access
      125I-BW-A844U, an antagonist radioligand with high affinity and selectivity for adenosine A1 receptors, and 125I-azido-BW-A844U, a photoaffinity label.
      A Patel, R H Craig, S M Daluge and J Linden
      Molecular Pharmacology June 1988, 33 (6) 585-591;
  2. Pessah, I N

    1. You have access
      Partial characterization of specific cantharidin binding sites in mouse tissues.
      M J Graziano, I N Pessah, M Matsuzawa and J E Casida
      Molecular Pharmacology June 1988, 33 (6) 706-712;
  3. Pool, W F

    1. You have access
      Stereoselectivity in the N'-oxidation of nicotine isomers by flavin-containing monooxygenase.
      L A Damani, W F Pool, P A Crooks, R K Kaderlik and D M Ziegler
      Molecular Pharmacology June 1988, 33 (6) 702-705;

R

  1. Reizes, O

    1. You have access
      Substrate properties of analogs of myo-inositol.
      J D Moyer, O Reizes, S Ahir, C Jiang, N Malinowski and D C Baker
      Molecular Pharmacology June 1988, 33 (6) 683-689;
  2. Reynolds, I J

    1. You have access
      Multiple sites for the regulation of the N-methyl-D-aspartate receptor.
      I J Reynolds and R J Miller
      Molecular Pharmacology June 1988, 33 (6) 581-584;
  3. Rosenberg, J

    1. You have access
      Messenger RNA loses the ability to direct in vitro peptide synthesis following incubation with cisplatin.
      J Rosenberg and P Sato
      Molecular Pharmacology June 1988, 33 (6) 611-616;
  4. Rudnick, G

    1. You have access
      Antidepressant binding to the porcine and human platelet serotonin transporters.
      C J Humphreys, J Levin and G Rudnick
      Molecular Pharmacology June 1988, 33 (6) 657-663;

S

  1. Saito, T

    1. You have access
      Effects of cholera toxin on the coupling of thyrotropin-releasing hormone to a guanine nucleotide-binding protein in cultured GH3 cells.
      Y Yajima, Y Akita and T Saito
      Molecular Pharmacology June 1988, 33 (6) 592-597;
  2. Saitoh, M

    1. You have access
      ML-9 inhibits the vascular contraction via the inhibition of myosin light chain phosphorylation.
      T Ishikawa, T Chijiwa, M Hagiwara, S Mamiya, M Saitoh and H Hidaka
      Molecular Pharmacology June 1988, 33 (6) 598-603;
  3. Sato, P

    1. You have access
      Messenger RNA loses the ability to direct in vitro peptide synthesis following incubation with cisplatin.
      J Rosenberg and P Sato
      Molecular Pharmacology June 1988, 33 (6) 611-616;
  4. Scherman, D

    1. You have access
      Ketanserin binds to the monoamine transporter of chromaffin granules and of synaptic vesicles.
      F Darchen, D Scherman, P M Laduron and J P Henry
      Molecular Pharmacology June 1988, 33 (6) 672-677;
  5. Simmons, M A

    1. You have access
      Role of phosphodiesterase in regulation of calcium current in isolated cardiac myocytes.
      M A Simmons and H C Hartzell
      Molecular Pharmacology June 1988, 33 (6) 664-671;

V

  1. Viganò, M A

    1. You have access
      Characterization of muscarinic receptors in guinea pig ileum longitudinal smooth muscle.
      E Giraldo, M A Viganò, R Hammer and H Ladinsky
      Molecular Pharmacology June 1988, 33 (6) 617-625;

W

  1. Walpole, C S

    1. You have access
      Long-lasting agonist activity produced by a capsaicin-like photoaffinity probe.
      I F James, C S Walpole, J Hixon, J N Wood and R Wrigglesworth
      Molecular Pharmacology June 1988, 33 (6) 643-649;
  2. Wang, H H

    1. You have access
      Noncompetitive inhibitors reach their binding site in the acetylcholine receptor by two different paths.
      M Blanton, E McCardy, T Gallaher and H H Wang
      Molecular Pharmacology June 1988, 33 (6) 634-642;
  3. Wood, J N

    1. You have access
      Long-lasting agonist activity produced by a capsaicin-like photoaffinity probe.
      I F James, C S Walpole, J Hixon, J N Wood and R Wrigglesworth
      Molecular Pharmacology June 1988, 33 (6) 643-649;
  4. Wrigglesworth, R

    1. You have access
      Long-lasting agonist activity produced by a capsaicin-like photoaffinity probe.
      I F James, C S Walpole, J Hixon, J N Wood and R Wrigglesworth
      Molecular Pharmacology June 1988, 33 (6) 643-649;

Y

  1. Yajima, Y

    1. You have access
      Effects of cholera toxin on the coupling of thyrotropin-releasing hormone to a guanine nucleotide-binding protein in cultured GH3 cells.
      Y Yajima, Y Akita and T Saito
      Molecular Pharmacology June 1988, 33 (6) 592-597;

Z

  1. Ziegler, D M

    1. You have access
      Stereoselectivity in the N'-oxidation of nicotine isomers by flavin-containing monooxygenase.
      L A Damani, W F Pool, P A Crooks, R K Kaderlik and D M Ziegler
      Molecular Pharmacology June 1988, 33 (6) 702-705;
Back to top
PreviousNext

In this issue

Molecular Pharmacology
Vol. 33, Issue 6
1 Jun 1988
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • SB-431542 Is a Potent and Specific Inhibitor of Transforming Growth Factor-β Superfamily Type I Activin Receptor-Like Kinase (ALK) Receptors ALK4, ALK5, and ALK7
  • The G-Protein-Coupled Receptors in the Human Genome Form Five Main Families. Phylogenetic Analysis, Paralogon Groups, and Fingerprints
  • Pharmacological Properties of Y-27632, a Specific Inhibitor of Rho-Associated Kinases
  • Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines.
  • The Orphan Human Pregnane X Receptor Mediates the Transcriptional Activation of CYP3A4 by Rifampicin through a Distal Enhancer Module
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics